Risk Factors and Molecular Mechanisms in Diabetes and Cardiovascular Complications
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Endocrinology and Metabolism Research".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 29
Special Issue Editor
Interests: heart failure; atrial fibrillation; clinical prognosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue aims to focus on research on the intricate interplay between diabetes mellitus and cardiovascular diseases (CVDs). We welcome original research articles and comprehensive reviews that explore a wide spectrum of topics, from established and emerging risk factors to the complex molecular mechanisms underpinning the development and progression of cardiovascular complications in diabetic patients. Particular emphasis will be placed on studies investigating novel biomarkers (such as the triglyceride–glucose index), the role of insulin resistance, and genetic and epigenetic predispositions to CVD in the context of diabetes. Furthermore, contributions elucidating the molecular pathways, such as non-coding RNAs and cell death mechanisms like PANoptosis, that link diabetes to atherosclerosis, ischemic heart disease, and other cardiovascular pathologies are highly encouraged. The goal is to foster a deeper understanding and highlight potential new avenues for risk stratification, prevention, and therapeutic intervention at the intersection of these two prevalent and debilitating conditions.
Dr. Xiao Liu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes
- cardiovascular disease
- atherosclerosis
- ischemic heart disease
- insulin resistance
- risk factors
- molecular mechanisms
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
